Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cardiol Therapeutics
(NQ:
CRDL
)
1.790
-0.050 (-2.72%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
104,739
Open
1.810
Bid (Size)
1.790 (1)
Ask (Size)
1.820 (9)
Prev. Close
1.840
Today's Range
1.740 - 1.840
52wk Range
0.5500 - 2.170
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023
April 02, 2024
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
February 21, 2024
This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)...
Via
Newsfile
Performance
YTD
+103.41%
+103.41%
1 Month
-0.56%
-0.56%
3 Month
+40.94%
+40.94%
6 Month
+113.10%
+113.10%
1 Year
+203.39%
+203.39%
More News
Read More
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
February 15, 2024
Via
Newsfile
Exposures
Product Safety
Cardiol Therapeutics - This Penny Stock Is An Analysts Favorite
January 31, 2024
Via
Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
Via
Benzinga
Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
November 01, 2023
Via
Newsfile
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Via
Get News
Topics
Death
Exposures
Death
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Via
News Direct
Topics
Death
Exposures
Death
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Via
TheNewswire.com
Topics
Death
Exposures
Death
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
October 12, 2023
Via
Benzinga
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
October 10, 2023
Via
Benzinga
Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction
October 10, 2023
Via
Newsfile
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
September 21, 2023
Via
Benzinga
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
September 19, 2023
Via
Newsfile
Sidoti's Micro-Cap Virtual May Conference
May 09, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Tuesday
October 04, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
Via
Benzinga
Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America
September 28, 2022
Via
Newsfile
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
July 26, 2022
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
The Healthcare Companies Fighting the World’s Biggest Killers
July 13, 2022
Via
FinancialNewsMedia
Tackling Recurring Health Conditions Offers Hope to Patients
June 21, 2022
Via
FinancialNewsMedia
As Health Problems Mount Patients Welcome New Treatments
June 14, 2022
Via
FinancialNewsMedia
Breakthroughs In Treating Killer Diseases Could Lengthen Life
June 07, 2022
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
May 31, 2022
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.